{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T12:38:49Z","timestamp":1793709529521,"version":"4.6.1"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:00:00Z","timestamp":1791936000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ijid.2026.109186","type":"journal-article","created":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T15:04:25Z","timestamp":1792422265000},"page":"109186","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Randomized controlled trial of pirfenidone XR for patients with COVID-19 and exploration of effects on long-COVID incidence"],"prefix":"10.1016","volume":"173","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6322-1079","authenticated-orcid":false,"given":"Karla M","family":"Tamez-Torres","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura Karina","family":"Aguilar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno Alejandro","family":"D\u00edaz-Mej\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morales-Ortega","family":"Maria de la Luz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis E","family":"Ram\u00edrez-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren","family":"Highstrete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adalberto S","family":"Gonz\u00e1lez-Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esteban","family":"P\u00e9rez-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid Vanessa","family":"Hern\u00e1ndez-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra","family":"Hern\u00e1ndez-Delgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadiel","family":"Hern\u00e1ndez-Aldana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro A","family":"Gorgonio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos A","family":"N\u00fa\u00f1ez-\u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego F","family":"Hern\u00e1ndez-Ram\u00edrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunice A","family":"Lara-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Alfonso","family":"Rumoroso-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelica","family":"Nava-Linares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Cervantes-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f3nica","family":"Chapa-Ibarg\u00fcengoitia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael R","family":"Valdez-Vazquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Ponce-de Le\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estuardo","family":"Aguilar-Cordova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura K","family":"Aguilar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Kershenobich-Stalnikowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Sifuentes-Osornio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2026.109186_bib0001","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1038\/s41591-020-1051-9","article-title":"An inflammatory cytokine signature predicts COVID-19 severity and survival","volume":"26","author":"Del Valle","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.ijid.2026.109186_bib0002","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1126\/science.abb8925","article-title":"Cytokine release syndrome in severe COVID-19","volume":"368","author":"Moore","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.ijid.2026.109186_bib0003","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.3390\/healthcare10122387","article-title":"Effect of Pirfenidone on risk of pulmonary fibrosis in COVID-19 patients experiencing cytokine storm","volume":"10","author":"Boshra","year":"2022","journal-title":"Healthcare"},{"key":"10.1016\/j.ijid.2026.109186_bib0004","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S2213-2600(20)30355-6","article-title":"Progressive fibrosing interstitial lung disease: clinical uncertainties, consensus recommendations, and research priorities","volume":"8","author":"George","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.ijid.2026.109186_bib0005","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S2213-2600(20)30222-8","article-title":"Pulmonary fibrosis secondary to COVID-19: a call to arms?","volume":"8","author":"Spagnolo","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.ijid.2026.109186_bib0006","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.jaci.2024.12.1074","article-title":"Long COVID: pathophysiology, current concepts, and future directions","volume":"155","author":"Skevaki","year":"2025","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.ijid.2026.109186_bib0007","unstructured":"Coronavirus disease (COVID-19) n.d. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/coronavirus-disease-(covid-19) [accessed 24 June 2026]."},{"key":"10.1016\/j.ijid.2026.109186_bib0008","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1038\/s41591-024-03173-6","article-title":"Long COVID science, research and policy","volume":"30","author":"Al-Aly","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/j.ijid.2026.109186_bib0009","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.ejphar.2008.06.046","article-title":"Antifibrotic action of pirfenidone and prednisolone: different effects on pulmonary cytokines and growth factors in bleomycin-induced murine pulmonary fibrosis","volume":"590","author":"Oku","year":"2008","journal-title":"Eur. J. Pharmacol"},{"key":"10.1016\/j.ijid.2026.109186_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.121048","article-title":"Investigating the possible mechanisms of pirfenidone to be targeted as a promising anti-inflammatory, anti-fibrotic, anti-oxidant, anti-apoptotic, anti-tumor, and\/or anti-SARS-CoV-2","volume":"309","author":"Antar","year":"2022","journal-title":"Life Sci"},{"key":"10.1016\/j.ijid.2026.109186_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2020.e05279","article-title":"Pharmacokinetic evaluation of two pirfenidone formulations in patients with idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis","volume":"6","author":"Barranco-Gardu\u00f1o","year":"2020","journal-title":"Heliyon"},{"key":"10.1016\/j.ijid.2026.109186_bib0012","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0244051","article-title":"Validation and repurposing of the MSL-COVID-19 score for prediction of severe COVID-19 using simple clinical predictors in a triage setting: the Nutri-CoV score","volume":"15","author":"Bello-Chavolla","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.ijid.2026.109186_bib0013","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/S0140-6736(23)00810-3","article-title":"6-month consequences of COVID-19 in patients discharged from hospital: a cohort study","volume":"401","author":"Huang","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2026.109186_bib0014","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1001\/jama.2023.8823","article-title":"Development of a definition of postacute sequelae of SARS-CoV-2 infection","volume":"329","author":"Thaweethai","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.ijid.2026.109186_bib0015","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1097\/CM9.0000000000001614","article-title":"A trial of pirfenidone in hospitalized adult patients with severe coronavirus disease 2019","volume":"135","author":"Zhang","year":"2022","journal-title":"Chin Med J"},{"key":"10.1016\/j.ijid.2026.109186_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2023.107362","article-title":"Prolonged-release pirfenidone in patients with pulmonary fibrosis as a phenotype of post-acute sequelae of COVID-19 pneumonia. Safety and efficacy","volume":"217","author":"Sansores","year":"2023","journal-title":"Respiratory Medicine"},{"key":"10.1016\/j.ijid.2026.109186_bib0017","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.medcli.2022.12.021","article-title":"Comparison of two antifibrotic treatments for lung fibrosis in post-COVID-19 syndrome: a randomized, prospective study","volume":"160","author":"Kerget","year":"2023","journal-title":"Medicina Cl\u00ednica"},{"key":"10.1016\/j.ijid.2026.109186_bib0018","doi-asserted-by":"crossref","first-page":"66","DOI":"10.5334\/gh.1452","article-title":"Long COVID syndrome, mortality and morbidity in patients hospitalized with COVID-19 from 16 countries: the World Heart Federation Global COVID-19 study","volume":"20","author":"Sliwa","year":"2025","journal-title":"Gh"},{"key":"10.1016\/j.ijid.2026.109186_bib0019","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1007\/s11606-022-07523-3","article-title":"Factors associated with post-acute sequelae of SARS-CoV-2 (PASC) after diagnosis of symptomatic COVID-19 in the inpatient and outpatient setting in a diverse cohort","volume":"37","author":"Yoo","year":"2022","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.ijid.2026.109186_bib0020","article-title":"Risk of developing long COVID based on acute COVID-19 severity","author":"Van Cleve","year":"2024","journal-title":"J Public Health (Berl)"},{"key":"10.1016\/j.ijid.2026.109186_bib0021","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-65302-0","article-title":"A systematic review and meta-analysis of the impact of vaccination on prevention of long COVID","volume":"16","author":"Green","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.ijid.2026.109186_bib0022","unstructured":"A Long COVID Definition n.d. https:\/\/www.nationalacademies.org\/projects\/HMD-HSP-23-01\/publication\/27768 [accessed 24 June 2026]."}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971226008210?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971226008210?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T12:19:37Z","timestamp":1793708377000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971226008210"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":22,"alternative-id":["S1201971226008210"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2026.109186","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Randomized controlled trial of pirfenidone XR for patients with COVID-19 and exploration of effects on long-COVID incidence","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2026.109186","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}],"article-number":"109186"}}